Drug Type Small molecule drug |
Synonyms Tamsulosin/finasteride |
Target |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors), α1A-AR antagonists(Alpha-1a adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H29ClN2O5S |
InChIKeyZZIZZTHXZRDOFM-XFULWGLBSA-N |
CAS Registry106463-17-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Hyperplasia | Phase 1 | KR | 01 Jan 2012 |